Related Experiment Video

Updated: Aug 30, 2025

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors
07:57

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors

Published on: January 20, 2023

5.8K

Targeting Heat-Shock Protein 90 in Cancer: An Update on Combination Therapy

Xiude Ren1,2, Tao Li1,2, Wei Zhang3,4

  • 1Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin 300052, China.

Cells
|August 26, 2022
PubMed

Insights

Heat-shock protein 90 (HSP90) aids cancer cell growth and survival. Combining HSP90 inhibitors with other cancer treatments shows promise for improved therapeutic strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Heat-shock protein 90 (HSP90) is a molecular chaperone crucial for cancer cell tumorigenesis and malignancy.
  • HSP90 regulates the folding and maturation of numerous oncogenic proteins, including kinases and transcription factors.
  • This chaperone activity supports cancer cell behaviors like proliferation, resistance to therapy, and immune evasion.

Purpose of the Study:

  • To review the critical role of HSP90 in cancer biology.
  • To discuss the therapeutic potential of HSP90 inhibitors as adjuncts to existing cancer treatments.

Main Methods:

  • Literature review of studies on HSP90 function in cancer.
  • Analysis of data regarding HSP90 inhibitors' efficacy and toxicity.
  • Evaluation of combination therapy strategies involving HSP90 inhibitors.

Main Results:

  • HSP90 is implicated in multiple hallmarks of cancer, making it a significant therapeutic target.
  • Numerous HSP90 inhibitors have been developed, but clinical approval as single agents is limited due to toxicity and efficacy issues.
  • Combination therapies involving HSP90 inhibitors show potential for enhanced anticancer effects.

Conclusions:

  • HSP90 plays a vital role in supporting cancer progression and malignancy.
  • Targeting HSP90 presents a promising therapeutic avenue, particularly when combined with other anticancer modalities.
  • Further research into combination strategies is warranted to overcome current limitations of HSP90 inhibitors.
Keywords:
HSP90cancer therapycombinational therapyheat-shock protein 90 inhibitorsmolecular chaperones

More Related Videos

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics08:29

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Published on: October 2, 2014

14.8K
Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay06:51

Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay

Published on: July 21, 2021

2.9K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
644
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
496